Cahill Represents ICON plc in its Acquisition of Symphony Clinical Research
Date: 10/24/19
Cahill represented ICON plc, a global provider of outsourced drug and device development and commercialization solutions and services to the pharmaceutical, biotechnology, medical device and government and public health organization, in connection with its acquisition of Symphony Clinical Research, a leading global provider of specialized in-home and alternate-site clinical services. The acquisition enhances ICON’s patient, site and data strategy and complements ICON’s existing PMG Research and MeDiNova Research site networks in the United States and EMEA.